Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00THG
|
|||
| Former ID |
DIB002643
|
|||
| Drug Name |
DE-105
|
|||
| Indication | Corneal disease [ICD-11: 9A78.Z] | Phase 2 | [1] | |
| Company |
Santen Pharmaceutical Co Ltd
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00988494) Study of DE-105 Ophthalmic Solution in Patients With Persistent Corneal Epithelial Defect. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.